Skip to main content
logo
Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
12.47
+0.02 (0.16%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Generate Biomedicines Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Cash & Equivalents
121.65176.27
Short-Term Investments
99.85217.36
Cash & Short-Term Investments
221.5393.63
Cash Growth
-43.73%-
Accounts Receivable
-0.31
Other Current Assets
12.8713.56
Total Current Assets
234.37407.49
Net Property, Plant & Equipment
89.01101.07
Other Long-Term Assets
6.819.7
Total Assets
330.18518.26
Accounts Payable
3.845.67
Accrued Expenses
42.1621.77
Current Portion of Leases
15.0116.72
Unearned Revenue
21.1942.43
Other Current Liabilities
-0.05
Total Current Liabilities
82.286.63
Long-Term Leases
53.5260.26
Other Long-Term Liabilities
5.8316.62
Total Long-Term Liabilities
59.3576.87
Total Liabilities
141.55163.5
Common Stock
0.030.03
Additional Paid-in Capital
60.1938.47
Accumulated Other Comprehensive Income
0.110.12
Retained Earnings
-676.29-473.14
Total Common Shareholders' Equity
-615.97-434.52
Minority Interest
804.59789.28
Shareholders' Equity
188.63354.76
Total Liabilities & Equity
330.18518.26
Total Debt
68.5376.97
Net Cash (Debt)
152.97316.66
Net Cash Growth
-51.69%-
Net Cash Per Share
4.649.87
Book Value
-615.97-434.52
Book Value Per Share
-18.68-13.54
Tangible Book Value
-615.97-434.52
Tangible Book Value Per Share
-18.68-13.54
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q